Drinker Biddle’s Pharma and Life Sciences Industry Group continues to host a series of webinars designed to help our clients navigate this dynamic, regulated industry environment. Our interdisciplinary group of attorneys and professionals present on topics of interest to pharmaceutical, medical device, life sciences, health care, and biotech companies, as well as contract research organizations, research institutions, scientists, venture capitalists and investment banks.
This webinar addressed key compliance issues related to the importation of pharmaceutical products and medical devices into the United States. Among other topics, we covered:
- Unique U.S. rules of origin for pharmaceutical products.
- The use of available duty preference programs, such as the Prototype Provision.
- CBP enforcement of retroactive import valuation issues related to the reporting of assists, royalties, and transfer price adjustments.
Questions? Please contact marc.kozak dbr.com